Royal Bank of Canada
KRSA

Royal Bank of Canada’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Royal Bank of Canada’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-59
Closed -$1K – 6953
2024
Q2 		$1K Buy
59
+9
+18% +$26 ﹤0.01% 6802
2024
Q1 		$1K Buy
50
+3
+6% +$10 ﹤0.01% 6774
2023
Q4 		$1K Sell
47
-83
-64% -$240 ﹤0.01% 6909
2023
Q3 		$3K Buy
130
+10
+8% +$36 ﹤0.01% 6710
2023
Q2 		$3K Buy
+120
New +$622 ﹤0.01% 6779
2023
Q1 		– Hold
0
– – – 7136
2022
Q4 		– Hold
0
– – – 7304
2022
Q3 		– Hold
0
– – – 7503
2022
Q2 		– Hold
0
– – – 7421
2022
Q1 		– Hold
0
– – – 7780
2021
Q4 		– Hold
0
– – – 7682
2021
Q3 		– Sell
-35
Closed -$2.29K – 7660
2021
Q2 		$19K Buy
35
+21
+150% +$1.31K ﹤0.01% 6584
2021
Q1 		$5K Sell
14
-5
-26% -$376 ﹤0.01% 7037
2020
Q4 		$8K Buy
19
+18
+1,800% +$1.23K ﹤0.01% 6470
2020
Q3 		$1K Hold
1
– – ﹤0.01% 6409
2020
Q2 		$0 Sell
1
-3
-75% -$251 ﹤0.01% 6668
2020
Q1 		$1K Buy
4
+3
+300% +$214 ﹤0.01% 6414
2019
Q4 		$0 Hold
1
– – ﹤0.01% 6861
2019
Q3 		$2K Hold
1
– – ﹤0.01% 6273
2019
Q2 		$2K Buy
+1
New +$283 ﹤0.01% 6559

Other funds holding KRSA

SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
TCP
Tyndall Capital Partners New York $452K AUM 26.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada's KRSA Position: Q3 2024 in Review

Royal Bank of Canada sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q3 2024, closing a stake of 59 shares — an estimated $1K sold.

Royal Bank of Canada first reported a position in KRSA in Q2 2019 and held it in 14 quarters. The position peaked at $19K in Q2 2021. 14 funds tracked by Wall St. Rank hold KRSA as of Q3 2024.

  • Royal Bank of Canada reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 59 Korsana Biosciences, Inc. Common Stock shares in Q3 2024, an estimated $1K.
  • Royal Bank of Canada first reported a position in Korsana Biosciences, Inc. Common Stock in Q2 2019 and held it in 14 quarters.
  • Royal Bank of Canada's Korsana Biosciences, Inc. Common Stock position peaked at $19K in Q2 2021.
  • 14 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.